trial · primary record
Nipocalimab
Thrombocytopenia, Neonatal Alloimmune
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 39 |
| Primary completion | 2029-12-05 |
| Primary endpoint | Fetus/Neonate with Outcome of Death or Adjudicated Severe Bleeding or Platelet Count Less Than (<) 30*10^9/L |
| Registry ID | NCT06449651 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:10.321Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06449651
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nipocalimab · compound